Julia Hippisley–Cox, Carol Coupland, John Robson, Aziz Sheikh et al.
OBJECTIVE: To develop and validate a new diabetes risk algorithm (the QDScore) for estimating 10 year risk of acquiring diagnosed type 2 diabetes over a 10 year time period in an ethnically and socioeconomically diverse population. DESIGN: Prospective open cohort study using routinely collected data...
Martina Patone, Andrew JHL Snelling, Holly Tibble, Carol Coupland et al.
ABSTRACT Sotrovimab is a neutralising monoclonal antibody (nMAB), currently administrated in England to treat extremely clinically vulnerable COVID-19 patients. Trials have shown it to have mild or moderate side effects, however safety in real-world settings has not been yet evaluated. We used natio...
Martina Patone, Andrew JHL Snelling, Holly Tibble, Carol Coupland et al.
Sotrovimab is a neutralising monoclonal antibody (nMAB) currently available to treat extremely clinically vulnerable COVID-19 patients in England. Trials have shown it to have mild to moderate side effects, however, evidence regarding its safety in real-world settings remains insufficient. Descripti...